Yingjun Su

发表

Mouse xenograft models vs GEM models for human cancer therapeutics

A. Richmond, Yingjun Su, 2008, Disease Models & Mechanisms.

LARP6 REGULATES KELOID FIBROBLASTS PROLIFERATION, INVASION AND COLLAGEN SYNTHESIS.

S. Li, Yingjun Su, Lin Chen, 2022, The Journal of investigative dermatology.

CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells

A. Richmond, Yingjun Su, Y. Ueda, 2007, Melanoma research.

Subcellular Distribution of ADAR1 Isoforms Is Synergistically Determined by Three Nuclear Discrimination Signals and a Regulatory Motif*

Y. Nie, Qingchuan Zhao, Yingjun Su, 2004, Journal of Biological Chemistry.

Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.

J. Van Damme, A. Richmond, E. Schutyser, 2007, European cytokine network.

Hypoxia enhances CXCR 4 expression in human microvascular endothelial cells and human melanoma cells

A. Richmond, E. Schutyser, J. Damme, 2007 .

Chemokine Regulation of Neutrophil Infiltration of Skin Wounds.

A. Richmond, Yingjun Su, 2014, Advances in wound care.

Mediate and Regulate Leukocyte Functions Protein-Coupled Receptor Kinases To CXCR2 Couple to Distinct G The Chemokine Receptors CXCR1 and

A. Richmond, Yingjun Su, R. Richardson, 2012 .

Bortezomib (B) and doxorubicin (dox) in patients (pts) with hepatocellular cancer (HCC): A phase II trial of the Eastern Cooperative Oncology Group (ECOG 6202) with laboratory correlates

J. Berlin, A. Benson, M. Mulcahy, 2008 .

Antioxidants tiron and N-acetyl-L-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-kappaB pathway.

A. Richmond, Yingjun Su, Jinming Yang, 2007, Free radical biology & medicine.

Expression pattern of the autophagy related proteins Beclin1 and LC3B in tuberculous wound tissues

Yingjun Su, Chiyu Jia, K. Zhou, 2021, European Journal of Inflammation.

MOB-1 and TNF-alpha interact to induce microvascular lung injury.

R. Rabinovici, Qingchuan Zhao, Yingjun Su, 2002, Shock.

The Lymphotoxin-β Receptor Is an Upstream Activator of NF-κB-mediated Transcription in Melanoma Cells*

C. Ware, P. Dhawan, M. Kelley, 2008, Journal of Biological Chemistry.

MOB-1 AND TNF- INTERACT TO INDUCE MICROVASCULAR LUNG INJURY

R. Rabinovici, Qingchuan Zhao, Yingjun Su, 2002 .

The Chemokine Receptors CXCR1 and CXCR2 Couple to Distinct G Protein-Coupled Receptor Kinases To Mediate and Regulate Leukocyte Functions

A. Richmond, Yingjun Su, R. Richardson, 2012, The Journal of Immunology.

MiR-19-3p Induces Tumor Cell Apoptosis via Targeting FAS in Rectal Cancer Cells

Yingjun Su, Yinlu Ding, Y. Zang, 2020, Technology in cancer research & treatment.

Intracellular Localization of Differentially Regulated RNA-specific Adenosine Deaminase Isoforms in Inflammation*

Y. Nie, R. Rabinovici, M. Pypaert, 2003, Journal of Biological Chemistry.

Widespread inosine‐containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation

Y. Nie, R. Rabinovici, Qingchuan Zhao, 2003, Immunology.

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group

J. Berlin, A. Benson, M. Mulcahy, 2014, Investigational New Drugs.

Short tail with skin lesion phenotype occurs in transgenic mice with keratin‐14 promoter‐directed expression of mutant CXCR2

A. Richmond, J. Sai, Yingjun Su, 2008, Journal of leukocyte biology.

Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence

R. Splittgerber, Yan Liu, J. Sosman, 2012, EMBO molecular medicine.

A Phase I Trial of Bortezomib with Temozolomide in Patients with Advanced Melanoma: Toxicities, Antitumor Effects, and Modulation of Therapeutic Targets

J. Sosman, G. Ayers, I. Puzanov, 2009, Clinical Cancer Research.

Altered CXCR2 Signaling in β-Arrestin-2-Deficient Mouse Models1

A. Richmond, L. Nanney, Yingjun Su, 2005, The Journal of Immunology.

Identifying changes in immune cells and constructing prognostic models using immune-related genes in post-burn immunosuppression

Yingjun Su, B. Yin, Peng Wang, 2022, PeerJ.

The good and the bad of chemokines/chemokine receptors in melanoma

A. Richmond, Yingjun Su, Jinming Yang, 2009, Pigment cell & melanoma research.

Cancer Therapy : Preclinical RAF 265 Inhibits the Growth of Advanced Human Melanoma Tumors

S. Levy, J. Sosman, R. Splittgerber, 2012 .

RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors

S. Levy, J. Sosman, R. Splittgerber, 2012, Clinical Cancer Research.

NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway

R. Splittgerber, A. Richmond, Yingjun Su, 2011, Oncogene.

Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials

William Pao, Mark C. Kelley, Ann Richmond, 2012, PloS one.

Characterization of Mycobacterium marinum infections in zebrafish wounds and sinus tracts

Yingjun Su, B. Yin, Ling Chen, 2017, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Foamy macrophages potentially inhibit tuberculous wound healing by inhibiting the TLRs/NF‐κB signalling pathway

Yingjun Su, B. Yin, W. Bao, 2022, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models.

A. Richmond, L. Nanney, Yingjun Su, 2005, Journal of immunology.

ADAR1 Is Involved in the Development of Microvascular Lung Injury

R. Rabinovici, Yingjun Su, Xiaoxing Luo, 2001, Circulation research.

Identification of new targets of Drosophila pre-mRNA adenosine deaminase.

E. Ma, G. Haddad, Jinghua Yang, 2005, Physiological genomics.